Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 4
1963 1
1964 2
1965 1
1966 1
1967 1
1968 1
1969 1
1971 1
1972 3
1973 8
1974 3
1975 2
1976 9
1977 3
1978 8
1979 4
1980 7
1981 14
1982 5
1983 5
1984 8
1985 4
1986 8
1987 13
1988 12
1989 11
1990 16
1991 14
1992 12
1993 15
1994 21
1995 24
1996 20
1997 27
1998 33
1999 38
2000 35
2001 37
2002 51
2003 48
2004 63
2005 67
2006 63
2007 121
2008 124
2009 126
2010 138
2011 155
2012 129
2013 168
2014 197
2015 178
2016 169
2017 154
2018 182
2019 171
2020 184
2021 235
2022 178
2023 172
2024 175
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,269 results

Results by year

Filters applied: . Clear all
Page 1
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.
Planchard D, Jänne PA, Cheng Y, Yang JC, Yanagitani N, Kim SW, Sugawara S, Yu Y, Fan Y, Geater SL, Laktionov K, Lee CK, Valdiviezo N, Ahmed S, Maurel JM, Andrasina I, Goldman J, Ghiorghiu D, Rukazenkov Y, Todd A, Kobayashi K; FLAURA2 Investigators. Planchard D, et al. Among authors: lee ck. N Engl J Med. 2023 Nov 23;389(21):1935-1948. doi: 10.1056/NEJMoa2306434. Epub 2023 Nov 8. N Engl J Med. 2023. PMID: 37937763 Clinical Trial.
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study.
Park K, Haura EB, Leighl NB, Mitchell P, Shu CA, Girard N, Viteri S, Han JY, Kim SW, Lee CK, Sabari JK, Spira AI, Yang TY, Kim DW, Lee KH, Sanborn RE, Trigo J, Goto K, Lee JS, Yang JC, Govindan R, Bauml JM, Garrido P, Krebs MG, Reckamp KL, Xie J, Curtin JC, Haddish-Berhane N, Roshak A, Millington D, Lorenzini P, Thayu M, Knoblauch RE, Cho BC. Park K, et al. Among authors: lee ck. J Clin Oncol. 2021 Oct 20;39(30):3391-3402. doi: 10.1200/JCO.21.00662. Epub 2021 Aug 2. J Clin Oncol. 2021. PMID: 34339292 Free PMC article. Clinical Trial.
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA; AURA3 Investigators. Mok TS, et al. Among authors: lee ck. N Engl J Med. 2017 Feb 16;376(7):629-640. doi: 10.1056/NEJMoa1612674. Epub 2016 Dec 6. N Engl J Med. 2017. PMID: 27959700 Free PMC article. Clinical Trial.
An A-Peeling Diagnosis.
Bhasin A, Lee CK, Shulman S, White AA, Stanley M. Bhasin A, et al. Among authors: lee ck. J Hosp Med. 2021 Jul 21. doi: 10.12788/jhm.3567. Online ahead of print. J Hosp Med. 2021. PMID: 34328832 No abstract available.
Interleukin 32, inflammation and cancer.
Hong JT, Son DJ, Lee CK, Yoon DY, Lee DH, Park MH. Hong JT, et al. Among authors: lee ck. Pharmacol Ther. 2017 Jun;174:127-137. doi: 10.1016/j.pharmthera.2017.02.025. Epub 2017 Feb 14. Pharmacol Ther. 2017. PMID: 28223235 Review.
The Reply.
Kwon OC, Hong S, Ghang B, Kim YG, Lee CK, Yoo B. Kwon OC, et al. Among authors: lee ck. Am J Med. 2017 Oct;130(10):e469. doi: 10.1016/j.amjmed.2017.06.030. Am J Med. 2017. PMID: 28927546 No abstract available.
Hepatitis C: Issues in Children.
Lee CK, Jonas MM. Lee CK, et al. Gastroenterol Clin North Am. 2015 Dec;44(4):901-9. doi: 10.1016/j.gtc.2015.07.011. Epub 2015 Aug 13. Gastroenterol Clin North Am. 2015. PMID: 26600227 Review.
3,269 results